Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

June 13, 2022

Study Completion Date

June 13, 2022

Conditions
Acne Scars - Mixed Atrophic and Hypertrophic
Interventions
DEVICE

Venus Viva MD

The Venus Viva™ MD fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, rhytids, and scars. Beginning with the Baseline visit (Visit 1), subjects will receive a total of 3 treatments approximately 3-5 weeks apart.

Trial Locations (1)

10075

Sadick Research Group, New York

All Listed Sponsors
lead

Venus Concept

INDUSTRY